Cargando…
Cellular Treatments for Spinal Cord Injury: The Time is Right for Clinical Trials
More than 1 million people in the United States live with a spinal cord injury (SCI). Despite medical advances, many patients with SCIs still experience substantial neurological disability, with loss of motor, sensory, and autonomic function. Cell therapy is ideally suited to address the multifactor...
Autores principales: | Fehlings, Michael G., Vawda, Reaz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3210356/ https://www.ncbi.nlm.nih.gov/pubmed/22002087 http://dx.doi.org/10.1007/s13311-011-0076-7 |
Ejemplares similares
-
Splenic involvement in umbilical cord matrix-derived mesenchymal stromal cell-mediated effects following traumatic spinal cord injury
por: Badner, Anna, et al.
Publicado: (2018) -
Current stem cell treatments for spinal cord injury
por: Vawda, R, et al.
Publicado: (2012) -
Harnessing the Secretome of Mesenchymal Stromal Cells for Traumatic Spinal Cord Injury: Multicell Comparison and Assessment of In Vivo Efficacy
por: Vawda, Reaz, et al.
Publicado: (2020) -
The timing of surgical decompression for spinal cord injury
por: Cadotte, David W, et al.
Publicado: (2010) -
Early Intravenous Infusion of Mesenchymal Stromal Cells Exerts a Tissue Source Age‐Dependent Beneficial Effect on Neurovascular Integrity and Neurobehavioral Recovery After Traumatic Cervical Spinal Cord Injury
por: Vawda, Reaz, et al.
Publicado: (2019)